Etravirine (ETR)

Paul A. Pham, Pharm.D. BCPS, Alice Jenh Hsu, Pharm.D
Etravirine (ETR) is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • In combination with other ARV agents for the treatment of HIV-1 infection in treatment-experienced pts with PIs, NRTIs, and NNRTI-resistant variants.
  • Treatment-experienced HIV-infected pediatric patients (6 -18 years of age and weighing at least 16 kg).

NON-FDA APPROVED USES

  • Potential for use in first-line therapy for pts infected with NNRTI-resistant virus (untested)

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: April 30, 2014

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Etravirine (ETR) ID - 540218 A1 - Hsu,Alice,Pharm.D AU - Pham,Paul,Pharm.D. BCPS Y1 - 2014/04/30/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540218/all/Etravirine__ETR_ PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -